Keyphrases
Adult Population
25%
Diagnosis Mechanism
100%
Drug Class
25%
Drug Therapy
25%
Echocardiographic
25%
Echocardiographic Parameters
25%
Fibroblast Growth Factor 1 (FGF1)
25%
Fibroblast Growth factor-2 (FGF-2)
25%
Group 1 Pulmonary Hypertension
25%
Group 3 Pulmonary Hypertension
100%
Growth Factors
25%
Hypoxia-induced Pulmonary Hypertension
100%
Molecular Mechanism
25%
Neonate
25%
Non-invasive Method
25%
Pathophysiological Mechanisms
100%
Pathophysiology
50%
Pediatric Population
25%
Platelet-derived Growth factor-BB (PDGF-BB)
50%
Pulmonary Hypertension
75%
Right Ventricle Function
25%
Right Ventricular
25%
Three-class
25%
Transforming Growth Factor-β
25%
Transforming Growth factor-β1 (TGF-β1)
25%
Unmet Medical Need
25%
Vascular Endothelial Growth Factor
50%
Biochemistry, Genetics and Molecular Biology
Animal Model
50%
Basic Fibroblast Growth Factor
50%
Drug Therapy
50%
Fibroblast Growth Factor
50%
Growth Factor
50%
Heart Right Ventricle Function
50%
Platelet Derived Growth Factor B
100%
Transforming Growth Factor Beta
50%
Vascular Endothelial Growth Factor
50%
Vascular Endothelial Growth Factor A
100%
Medicine and Dentistry
Biological Marker
12%
Diseases
12%
Drug Therapy
12%
Fibroblast Growth Factor
12%
Fibroblast Growth Factor 2
12%
Growth Factor
12%
Heart Right Ventricle Function
12%
Hypoxia-Induced Pulmonary Hypertension
100%
Neonate
12%
Non Invasive Procedure
12%
Pathophysiology
25%
Pediatrics
12%
Platelet Derived Growth Factor B
25%
Pulmonary Hypertension
100%
Transforming Growth Factor Beta
12%
Vasculotropin
12%
Vasculotropin A
25%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
12%
Diseases
12%
Fibroblast Growth Factor
12%
Fibroblast Growth Factor 2
12%
Growth Factor
12%
Hypoxia-Induced Pulmonary Hypertension
100%
Pathophysiology
25%
Pharmacotherapy
12%
Platelet Derived Growth Factor B
25%
Pulmonary Hypertension
100%
Transforming Growth Factor Beta
12%
Vasculotropin
12%
Vasculotropin A
25%